Evidence map›Paper›PMID 41198371›Full record

ReviewJACC. Asia2025

Epidemiology of Myocarditis in Young and Middle-Aged Population in Asia.

Chenze Li, Zhibing Lu, Dao Wen Wang

Abstract readReview
In one paragraph

Review in JACC. Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chenze LiDepartment of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Institute of Myocardial Injury and Repair, Hubei Provincial Clinical Research Center for Cardiovascular Intervention, Wuhan University, Wuhan, Hubei, China.
Zhibing LuDepartment of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Institute of Myocardial Injury and Repair, Hubei Provincial Clinical Research Center for Cardiovascular Intervention, Wuhan University, Wuhan, Hubei, China. Electronic address: luzhibing222@163.com.
Dao Wen WangDivision of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, Hubei, China. Electronic address: dwwang@tjh.tjmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocarditis, characterized by inflammation of the myocardium and subsequent injury of cardiac function, has garnered increasing attention among the young and middle-aged population in Asia. Its epidemiology is influenced by a combination of environmental factors, genetic predisposition, and socioeconomic status. Global disease burden analyses indicate that the prevalence of myocarditis varies by region, with certain areas in Asia reporting higher rates. However, the true burden is likely underestimated due to clinical underdiagnosis and inadequate health surveillance. Regarding prognosis, most acute cases may recover, but persistent subclinical abnormalities often remain. Notably, the most severe form, fulminant myocarditis, is associated with a high in-hospital mortality rate when treated conventionally. Nevertheless, early implementation of a life support-based treatment can significantly improve outcomes. This review focuses on summarizing the epidemiology of myocarditis in the young and middle-aged Asian population, aiming to provide a theoretical foundation for enhancing the management of myocarditis in this demographic in the future.

Indexed as

Asiaepidemiologymyocarditisyoung and middle-aged population

Identifiers

PMID41198371
PMCPMC12673831

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.